Wellgistics Health's 200% Increase Highlights AI-Pharma Partnerships in ETFs
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 24 2025
0mins
Source: Benzinga
Wellgistics Health Inc Surge: Wellgistics Health Inc (WGRX) saw its stock price soar over 200% following a collaboration announcement with Datavault AI Inc (DVLT) to integrate blockchain technology into pharmaceutical logistics, attracting significant attention from investors and ETFs focused on AI and healthcare.
Convergence of Technologies: The partnership aligns with a growing trend of merging AI, blockchain, and healthcare innovation, with thematic ETFs like ARK Genomic Revolution ETF and ROBO Global Healthcare Technology and Innovation ETF already capitalizing on this convergence.
PharmacyChain Platform: The collaboration aims to develop the PharmacyChain platform, which will enhance transparency in drug tracking and address longstanding issues in pharmacy logistics, while also exploring a revenue-sharing model for platform usage.
Technological Advancements: This initiative follows Wellgistics' launch of HubRx AI, its proprietary AI platform for pharmacy operations, indicating a strong commitment to leveraging technology for improved efficiency in the healthcare supply chain.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DVLT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DVLT
Wall Street analysts forecast DVLT stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.556
Low
4.00
Averages
4.00
High
4.00
Current: 0.556
Low
4.00
Averages
4.00
High
4.00
About DVLT
Datavault AI Inc., formerly WiSA Technologies Inc., is a technology licensing company. The Company's offerings are its artificial intelligence (AI)-driven agents branded as Data Vault, DataValue, DataScore, and Data Vault Bank. It operates through two synergistic platforms: Data Science and Acoustic Science. The Data Sciences division develops and operates tools for the capture, processing, and compliant monetization of data. The division is also focused on the delivery of cyber-secure, privacy protected data management and monetization technologies. Its flagship information data exchange (IDE) is a patented Web 3.0 platform. The Acoustic Sciences Platform features a fusion of WiSA's wireless standard technology and the category creating ADIO inaudible tone, data over sound, and mobile quick response technology. Acoustic Sciences also includes a fusion of its multi-patented, spatial, multichannel, HD wireless sound transmission WiSA HT and WiSA E technologies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Datavault AI Signs $2B Financing Term Sheet
- Financing Agreement Overview: Datavault AI has signed a non-binding term sheet to potentially raise up to $2 billion by issuing shares at $1.55 to $2.00 per share to institutional investors, aimed at supporting the expansion of its digital asset trading platform.
- Tranche Financing Structure: The transaction is anticipated to be structured in four tranches, each worth up to $500 million, totaling $2 billion, with the first tranche expected to close by Q3 2026, thereby providing the company with a stable funding source to enhance its market competitiveness.
- Exclusive Partnership Agreement: The counterparty has agreed to route all digital asset tokenization projects exclusively through Datavault AI's platform, ensuring the company's leading position in the digital asset space and laying a foundation for future growth.
- Board Change Mechanism: Upon the closing of each tranche, the counterparty will have the right to nominate one new director to replace a current board member, a mechanism that will help strengthen the partnership and improve corporate governance.
See More
Datavault AI Secures Exclusive Partnership for Digital Asset Tokenization
- Exclusive Partnership Agreement: The Counterparty has agreed to route all global digital asset tokenization and blockchain infrastructure initiatives exclusively through Datavault AI's patented platform, enhancing Datavault AI's leadership position in the market.
- Innovative Financing Structure: The proposed transaction is expected to be anchored by an approximately $2.0 billion portfolio of fixed income securities, supporting Datavault AI's digital asset exchange financing, with anticipated share prices between $1.55 and $2.00, reflecting strong market confidence.
- Board Power Shift: With the completion of each $500 million tranche, the Counterparty will have the right to nominate additional directors, potentially granting it majority voting power on Datavault AI's board, thereby influencing corporate governance.
- Optimistic Market Outlook: The tokenized real-world asset market is projected to reach $18.9 trillion by 2033, and Datavault AI's technology platforms are set to provide the infrastructure for this rapidly growing market, driving future revenue growth for the company.
See More
Datavault AI Signs Agreement with Perpetuals for $328M Commodity Token Programs
- Agreement Overview: Datavault AI's signed agreement with Perpetuals.com covers over $328 million in commodity token programs, enabling global investors to trade physical asset tokens on regulated platforms 24/7, significantly enhancing market liquidity and investment opportunities.
- Project Expansion Potential: The agreement initially includes the MTB Copper project, with provisions for future expansion into gold, geothermal energy, and strategic minerals, which is expected to attract more investors into this emerging market.
- Market Impact: Datavault AI signed over $800 million in tokenization contracts in Q1 2026 alone, marking robust growth in the global commodity market and further solidifying its leadership position in the digital asset space.
- Technological and Compliance Advantages: By partnering with Perpetuals, Datavault AI will leverage its patented blockchain platform for compliant token issuance and trading, ensuring investors can trade in a regulated environment compliant with MiFID II and EMIR, thereby enhancing market trust and security.
See More
Formation of DelivMeds AI with Approximate Asset Value of $4 Billion
- Asset Value: The formation of DelivMeds AI is expected to have an approximate asset value of $4 billion, stemming from a comprehensive partnership between Datavault AI and Wellgistics Health aimed at enhancing healthcare service efficiency through blockchain and AI integration, thereby securing a competitive edge in the rapidly evolving healthcare market.
- Technology Integration and Expansion: The fully binding term sheet signed between Datavault AI and Wellgistics Health expands the PharmacyChain™ platform to include Healthcare-as-a-Service (HaaS), connecting over 6,500 pharmacies and 200 manufacturers, significantly improving the efficiency and transparency of pharmaceutical delivery.
- Innovative Healthcare Solutions: Following the acquisition of the QOLPOM patent portfolio, DelivMeds AI will leverage biometric verification and AI-driven drones to enhance pharmaceutical delivery and sample collection in rural areas, which is expected to greatly improve accessibility and compliance in healthcare services.
- Market Promotion and Collaboration: The
See More
Datavault AI Q1 2026 Earnings Call Highlights
- Revenue Target Unchanged: Datavault AI's Chairman and CFO Brett Moyer stated that the 2026 revenue target of $200 million remains unchanged, although it is expected to be more heavily weighted towards the second half of the year, reflecting the company's confidence in future earnings.
- Significant Contract Value: The company signed $800 million in tokenization contracts during the quarter, which are expected to generate approximately $90 million in fees, establishing a robust foundation for future revenue growth.
- Accelerated Financing Plan: Datavault AI announced the execution of a $120 million nondilutive financing agreement to expedite the nationwide rollout of the SanQtum platform, enhancing its competitive position in the market and supporting business expansion.
- Upcoming Exchange Launch: The company plans to launch its exchanges in July, with management emphasizing that this timing is closely tied to the passage of the CLARITY Act, which is expected to make July the biggest revenue month in the company's history, demonstrating a keen awareness of market opportunities.
See More
DataVault's Q1 Results Disappoint, Stock Continues Downward Trend
- Disappointing Performance: DataVault reported a Q1 GAAP EPS loss of $0.09, missing estimates by $0.01, and despite a remarkable 443% YoY revenue growth to $3.42 million, it fell short of expectations by nearly $16.6 million, undermining investor confidence.
- Stock Price Decline: The company's stock has dropped nearly 24% over the past month, falling another ~10% on Friday to around $0.53, resulting in a YTD return of -19.78%, significantly lagging behind the S&P 500's 9.59% gain.
- Long-Term Growth Potential: Despite the short-term setbacks, DataVault AI demonstrated strong momentum in its tokenization business, signing contracts exceeding $800 million, expected to generate nearly $100 million in fees by 2026, indicating future growth prospects.
- Funding and Strategic Plans: The company reiterated its FY26 revenue target of at least $200 million while strengthening its balance sheet through a $60 million stock offering and securing an additional $120 million in non-dilutive funding to support its SanQtum AI infrastructure rollout.
See More
Datavault AI Signs $2B Financing Term Sheet
- Financing Agreement Overview: Datavault AI has signed a non-binding term sheet to potentially raise up to $2 billion by issuing shares at $1.55 to $2.00 per share to institutional investors, aimed at supporting the expansion of its digital asset trading platform.
- Tranche Financing Structure: The transaction is anticipated to be structured in four tranches, each worth up to $500 million, totaling $2 billion, with the first tranche expected to close by Q3 2026, thereby providing the company with a stable funding source to enhance its market competitiveness.
- Exclusive Partnership Agreement: The counterparty has agreed to route all digital asset tokenization projects exclusively through Datavault AI's platform, ensuring the company's leading position in the digital asset space and laying a foundation for future growth.
- Board Change Mechanism: Upon the closing of each tranche, the counterparty will have the right to nominate one new director to replace a current board member, a mechanism that will help strengthen the partnership and improve corporate governance.
See More
Datavault AI Secures Exclusive Partnership for Digital Asset Tokenization
- Exclusive Partnership Agreement: The Counterparty has agreed to route all global digital asset tokenization and blockchain infrastructure initiatives exclusively through Datavault AI's patented platform, enhancing Datavault AI's leadership position in the market.
- Innovative Financing Structure: The proposed transaction is expected to be anchored by an approximately $2.0 billion portfolio of fixed income securities, supporting Datavault AI's digital asset exchange financing, with anticipated share prices between $1.55 and $2.00, reflecting strong market confidence.
- Board Power Shift: With the completion of each $500 million tranche, the Counterparty will have the right to nominate additional directors, potentially granting it majority voting power on Datavault AI's board, thereby influencing corporate governance.
- Optimistic Market Outlook: The tokenized real-world asset market is projected to reach $18.9 trillion by 2033, and Datavault AI's technology platforms are set to provide the infrastructure for this rapidly growing market, driving future revenue growth for the company.
See More
Datavault AI Signs Agreement with Perpetuals for $328M Commodity Token Programs
- Agreement Overview: Datavault AI's signed agreement with Perpetuals.com covers over $328 million in commodity token programs, enabling global investors to trade physical asset tokens on regulated platforms 24/7, significantly enhancing market liquidity and investment opportunities.
- Project Expansion Potential: The agreement initially includes the MTB Copper project, with provisions for future expansion into gold, geothermal energy, and strategic minerals, which is expected to attract more investors into this emerging market.
- Market Impact: Datavault AI signed over $800 million in tokenization contracts in Q1 2026 alone, marking robust growth in the global commodity market and further solidifying its leadership position in the digital asset space.
- Technological and Compliance Advantages: By partnering with Perpetuals, Datavault AI will leverage its patented blockchain platform for compliant token issuance and trading, ensuring investors can trade in a regulated environment compliant with MiFID II and EMIR, thereby enhancing market trust and security.
See More
Formation of DelivMeds AI with Approximate Asset Value of $4 Billion
- Asset Value: The formation of DelivMeds AI is expected to have an approximate asset value of $4 billion, stemming from a comprehensive partnership between Datavault AI and Wellgistics Health aimed at enhancing healthcare service efficiency through blockchain and AI integration, thereby securing a competitive edge in the rapidly evolving healthcare market.
- Technology Integration and Expansion: The fully binding term sheet signed between Datavault AI and Wellgistics Health expands the PharmacyChain™ platform to include Healthcare-as-a-Service (HaaS), connecting over 6,500 pharmacies and 200 manufacturers, significantly improving the efficiency and transparency of pharmaceutical delivery.
- Innovative Healthcare Solutions: Following the acquisition of the QOLPOM patent portfolio, DelivMeds AI will leverage biometric verification and AI-driven drones to enhance pharmaceutical delivery and sample collection in rural areas, which is expected to greatly improve accessibility and compliance in healthcare services.
- Market Promotion and Collaboration: The
See More
Datavault AI Q1 2026 Earnings Call Highlights
- Revenue Target Unchanged: Datavault AI's Chairman and CFO Brett Moyer stated that the 2026 revenue target of $200 million remains unchanged, although it is expected to be more heavily weighted towards the second half of the year, reflecting the company's confidence in future earnings.
- Significant Contract Value: The company signed $800 million in tokenization contracts during the quarter, which are expected to generate approximately $90 million in fees, establishing a robust foundation for future revenue growth.
- Accelerated Financing Plan: Datavault AI announced the execution of a $120 million nondilutive financing agreement to expedite the nationwide rollout of the SanQtum platform, enhancing its competitive position in the market and supporting business expansion.
- Upcoming Exchange Launch: The company plans to launch its exchanges in July, with management emphasizing that this timing is closely tied to the passage of the CLARITY Act, which is expected to make July the biggest revenue month in the company's history, demonstrating a keen awareness of market opportunities.
See More
DataVault's Q1 Results Disappoint, Stock Continues Downward Trend
- Disappointing Performance: DataVault reported a Q1 GAAP EPS loss of $0.09, missing estimates by $0.01, and despite a remarkable 443% YoY revenue growth to $3.42 million, it fell short of expectations by nearly $16.6 million, undermining investor confidence.
- Stock Price Decline: The company's stock has dropped nearly 24% over the past month, falling another ~10% on Friday to around $0.53, resulting in a YTD return of -19.78%, significantly lagging behind the S&P 500's 9.59% gain.
- Long-Term Growth Potential: Despite the short-term setbacks, DataVault AI demonstrated strong momentum in its tokenization business, signing contracts exceeding $800 million, expected to generate nearly $100 million in fees by 2026, indicating future growth prospects.
- Funding and Strategic Plans: The company reiterated its FY26 revenue target of at least $200 million while strengthening its balance sheet through a $60 million stock offering and securing an additional $120 million in non-dilutive funding to support its SanQtum AI infrastructure rollout.
See More
